NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for October 20131. Global derivatives average daily volume ("ADV") of 6.5 million contracts, excluding Bclear in October 2013 increased 1.3% compared to October 2012, but decreased 1.3% from September 2013. U.S. equity options volumes in October 2013 decreased 2.9% compared to October 2012, but increased 7.7% sequentially. ADV in U.S. cash equities declined 4.8% year-over-year and decreased 3.5% month-over-month. European cash equities ADV in October 2013 increased 8.1% compared to October 2012 and increased 3.0% from September 2013 levels.

Highlights

  • NYSE Euronext global derivatives ADV in October 2013 of 6.5 million contracts, excluding Bclear increased 1.3% from October 2012, but decreased 1.3% from September 2013 levels.
  • NYSE Euronext European derivatives products ADV in October 2013 of 2.5 million contracts, excluding Bclear, increased 9.2% compared to October 2012, but decreased 11.3% from September 2013 levels. Including Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives ADV decreased 7.5% compared to October 2012 and decreased 8.2% from September 2013.
  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options) ADV of 3.9 million contracts in October 2013 decreased 2.9% compared to October 2012 levels, but increased 7.7% from September 2013 levels. NYSE Euronext's U.S. options exchanges accounted for 25.0% of total U.S. consolidated equity options trading in October 2013, down from 28.5% in October 2012 and down from 25.5% in September 2013.
  • NYSE Liffe U.S. ADV of approximately 30,000 contracts decreased from 43,700 contracts in October 2012 and decreased from 73,700 contracts in September 2013.
  • NYSE Euronext European cash products ADV of 1.4 million transactions in October 2013 increased 8.1% compared to October 2012 and increased 3.0% compared to September 2013.
  • NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE MKT) handled ADV of 1.5 billion shares in October 2013 decreased 4.8% compared to October 2012 and decreased 3.5% compared to September 2013. NYSE Euronext's Tape A matched market share in October 2013 was 29.4%, down from 30.6% in October 2012 and down from 31.3% in September 2013.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. For more information, please visit: http://www.nyx.com.

Please follow us at:
Exchanges Blog
Facebook
LinkedIn
Twitter

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

This written communication contains "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "may," "hope," "will," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," "continue," "could," "future" or the negative of those terms or other words of similar meaning. You should carefully read forward-looking statements, including statements that contain these words, because they discuss our future expectations or state other "forward-looking" information. Forward-looking statements are subject to numerous assumptions, risks and uncertainties which change over time. ICE Group, ICE and NYSE Euronext caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement.

Forward-looking statements include, but are not limited to, statements about the benefits of the proposed merger involving ICE Group, ICE and NYSE Euronext, including future financial results, ICE's and NYSE Euronext's plans, objectives, expectations and intentions, the expected timing of completion of the transaction and other statements that are not historical facts. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in ICE's and NYSE Euronext's filings with the U.S. Securities and Exchange Commission (the "SEC"). These risks and uncertainties include, without limitation, the following: the inability to close the merger in a timely manner; the failure to satisfy other conditions to completion of the merger, including receipt of required regulatory and other approvals; the failure of the proposed transaction to close for any other reason; the possibility that any of the anticipated benefits of the proposed transaction will not be realized; the risk that integration of NYSE Euronext's operations with those of ICE will be materially delayed or will be more costly or difficult than expected; the challenges of integrating and retaining key employees; the effect of the announcement of the transaction on ICE's, NYSE Euronext's or the combined company's respective business relationships, operating results and business generally; the possibility that the anticipated synergies and cost savings of the merger will not be realized, or will not be realized within the expected time period; the possibility that the merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management's attention from ongoing business operations and opportunities; general competitive, economic, political and market conditions and fluctuations; actions taken or conditions imposed by the United States and foreign governments or regulatory authorities; and adverse outcomes of pending or threatened litigation or government investigations. In addition, you should carefully consider the risks and uncertainties and other factors that may affect future results of the combined company, as are described in the section entitled "Risk Factors" in the joint proxy statement/prospectus filed by ICE Group with the SEC, and as described in ICE's and NYSE Euronext's respective filings with the SEC that are available on the SEC's web site located at www.sec.gov, including the sections entitled "Risk Factors" in ICE's Form 10-K for the fiscal year ended December 31, 2012, as filed with the SEC on February 6, 2013, and "Risk Factors" in NYSE Euronext's Form 10-K for the fiscal year ended December 31, 2012, as filed with the SEC on February 26, 2013. You should not place undue reliance on forward-looking statements, which speak only as of the date of this written communication. Except for any obligations to disclose material information under the Federal securities laws, ICE Group, ICE and NYSE Euronext undertake no obligation to publicly update any forward-looking statements to reflect events or circumstances after the date of this written communication.

IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE TO FIND IT

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. In connection with the proposed transaction, ICE Group has filed with the SEC a registration statement on Form S?'4, which the SEC has declared effective and which contains a joint proxy statement/prospectus with respect to the proposed acquisition of NYSE Euronext by ICE Group. The final joint proxy statement/prospectus has been delivered to the stockholders of ICE and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION. Investors and security holders may obtain a free copy of the joint proxy statement/prospectus, as well as other filings containing information about ICE and NYSE Euronext, without charge, at the SEC's website at http://www.sec.gov. Investors may also obtain these documents, without charge, from ICE's website at http://www.theice.com and from NYSE Euronext's website at http://www.nyx.com.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary

 
  Average Daily Volume   Total Volume   Average Daily Volume   Total Volume
         

% Chg vs.

  

% Chg vs.

(Unaudited; contracts in thousands) Oct-13Oct-12

% Chg

Oct-13Oct-12% ChgYTD 2013

YTD 2012

YTD 2013

YTD 2012

Number of Trading Days - European Cash 23 23 23 23 214 214
Number of Trading Days - European Derivatives 23 23 23 23 215 215
Number of Trading Days - U.S. Markets 23 21 23 21 211 211
European Derivatives Products 2,905 3,140 -7.5% 66,819 72,218 -7.5% 3,778 1.8% 812,197 1.3%
of which Bclear 394 841 -53.1% 9,063 19,335 -53.1% 657 -49.9% 141,162 -37.7%
 
Total Fixed Income Products 1,737 1,523 14.1% 39,953 35,029 14.1% 2,316 29.6% 497,848 29.0%
 
Short Term Interest Rate Products 1,605 1,383 16.0% 36,919 31,814 16.0% 2,143 30.9% 460,758 30.3%

Medium and Long Term Interest Rate Products 1

 132 140 -5.6% 3,035 3,215 -5.6% 173 15.4% 37,090 14.8%
 

Total Equity Products 2

1,048 1,511 -30.6% 24,114 34,755 -30.6% 1,367 -25.6% 293,960 -25.9%
 
Individual Equity Products 627 1,107 -43.4% 14,416 25,458 -43.4% 877 -35.4% 188,530 -35.7%
Futures 247 715 -65.4% 5,692 16,445 -65.4% 485 -46.5% 104,250 -46.8%
Options 379 392 -3.2% 8,724 9,014 -3.2% 392 -13.1% 84,281 -13.5%
Equity Index Products 422 404 4.3% 9,698 9,297 4.3% 490 2.4% 105,429 1.9%
 
of which Bclear 393 841 -53.2% 9,047 19,335 -53.2% 655 -50.0% 140,893 -37.9%
Individual Equity Products 320 778 -58.9% 7,363 17,896 -58.9% 559 -54.2% 120,155 -43.0%
Futures 246 710 -65.3% 5,666 16,322 -65.3% 473 -57.1% 101,667 -46.7%
Options 74 68 7.9% 1,697 1,573 7.9% 86 -25.9% 18,488 -7.9%
Equity Index Products 73 63 17.0% 1,684 1,439 17.0% 96 5.5% 20,737 31.1%
 
Commodity Products 120 106 13.0% 2,751 2,434 13.0% 95 6.7% 20,390 6.2%
 
U.S. Derivatives Products
 

Equity Options 3

 
NYSE Euronext Options Contracts 3,921 4,039 -2.9% 90,192 84,817 6.3% 4,023 3.8% 848,914 4.8%
Total Consolidated Options Contracts 15,684 14,190 10.5% 360,730 297,991 21.1% 14,919 0.8% 3,147,981 1.8%
 
NYSE Group Share of Total 25.0% 28.5% 25.0% 28.5% 27.0% 0.8% 27.0% 0.8%
 
NYSE Liffe U.S.
 
Futures and Futures Options Volume* 30.0 43.7 -31.4% 690 1,006 -31.4% 53.2 -29.0% 11,485.7 -29.0%
 
European Cash Products (trades in thousands) 1,383 1,279 8.1% 31,804 29,421 8.1% 1,393 -7.5% 298,175 -8.0%
 
Equities 1,338 1,233 8.5% 30,778 28,364 8.5% 1,345 -7.7% 287,814 -8.1%
Exchange-Traded Funds 12 12 7.1% 287 267 7.1% 14 -0.1% 2,902 -0.5%
Structured Products 28 29 -2.6% 639 656 -2.6% 30 -4.4% 6,450 -4.9%
Bonds 4 6 -25.3% 100 133 -25.3% 5 -8.5% 1,009 -9.0%
 

U.S. Cash Products (shares in millions) 5

1,461 1,536 -4.8% 33,612 32,251 4.2% 1,520 -11.1% 320,789 -10.3%
 
NYSE Listed (Tape A) Issues 4
 
Handled Volume 5 1,025 1,103 -7.1% 23,565 23,157 1.8% 1,085 -11.4% 228,875 -10.5%
Matched Volume 6 991 1,052 -5.8% 22,782 22,083 3.2% 1,046 -9.9% 220,738 -9.0%
Total NYSE Listed Consolidated Volume 3,371 3,439 -2.0% 77,524 72,216 7.4% 3,435 -7.5% 724,685 -6.6%
 
Share of Total Consolidated Volume
Handled Volume 5 30.4% 32.1% -1.7% 30.4% 32.1% -1.7% 31.6% -1.4% 31.6% -1.4%
Matched Volume 6 29.4% 30.6% -1.2% 29.4% 30.6% -1.2% 30.5% -0.8% 30.5% -0.8%
 
NYSE Arca, MKT and Regional (Tape B) Listed Issues
 
Handled Volume 5 247 214 15.7% 5,689 4,491 26.7% 251 -0.3% 52,883 0.7%
Matched Volume 6 229 198 15.9% 5,274 4,154 27.0% 231 2.0% 48,789 2.9%
Total NYSE Arca & MKT Listed Consolidated Volume 1,059 932 13.6% 24,348 19,567 24.4% 1,088 1.9% 229,540 2.8%
 
Share of Total Consolidated Volume
Handled Volume 5 23.4% 23.0% 0.4% 23.4% 23.0% 0.4% 23.0% -0.5% 23.0% -0.5%
Matched Volume 6 21.7% 21.2% 0.5% 21.7% 21.2% 0.5% 21.3% 0.0% 21.3% 0.0%
 
Nasdaq Listed (Tape C) Issues
 
Handled Volume 5 189 219 -13.6% 4,357 4,603 -5.3% 185 -21.3% 39,030 -20.5%
Matched Volume 6 168 195 -13.6% 3,872 4,094 -5.4% 165 -18.2% 34,818 -17.4%
Total Nasdaq Listed Consolidated Volume 1,885 1,747 7.9% 43,346 36,692 18.1% 1,758 0.3% 371,011 1.3%
 
Share of Total Consolidated Volume
Handled Volume 5 10.1% 12.5% -2.4% 10.1% 12.5% -2.4% 10.5% -2.9% 10.5% -2.9%
Matched Volume 6 8.9% 11.2% -2.3% 8.9% 11.2% -2.3% 9.4% -2.1% 9.4% -2.1%
 
Exchange-Traded Products 5,7
 
Handled Volume 5 233 205 13.8% 5,362 4,300 24.7% 234 -0.6% 49,455 0.3%
Matched Volume 6 216 190 13.9% 4,976 3,990 24.7% 216 1.7% 45,621 2.7%
Total ETF Consolidated Volume 1,016 903 12.6% 23,373 18,961 23.3% 1,041 0.9% 219,662 1.8%
 
Share of Total Consolidated Volume
Handled Volume 5 22.9% 22.7% 0.2% 22.9% 22.7% 0.2% 22.5% -0.3% 22.5% -0.3%
Matched Volume 6 21.3% 21.0% 0.3% 21.3% 21.0% 0.3% 20.8% 0.2% 20.8% 0.2%
1   Data includes currency products.

2

 Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
3 Includes trading in U.S. equity options contracts, not equity-index options.
4 Includes all volume executed in NYSE Group crossing sessions.
5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
7 Data included in previously identified categories.
* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

NYSE Euronext
Media:
Amsterdam, +31-20-550-4488
Lisbon, +351-217-900-029
New York, +1-212-656-2411
Brussels, +32-2-509-1392
London, +44-20-7379-2789
Paris, +33-1-49-27-11-33
or
Investor Relations:
New York, +1-212-656-5700
nyx.com